Tarsons Products (NSE:TARSONS) Beta: 1.9480 (As of Jul. 03, 2026)


NSE:TARSONS Tarsons Products Ltd NSE:TARSONS
78 GF Score
Price ₹265.05
GF Value ₹564.22
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Tarsons Products Beta?

Tarsons Products NSE:TARSONS +1.36% 78 Beta is 1.9480 as of Jul. 03, 2026. GuruFocus rates NSE:TARSONS with a GF Score™ of 78/100 and a GF Value™ of ₹564.22 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-03), Tarsons Products's Beta is 1.9480.


Tarsons Products  (NSE:TARSONS) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Tarsons Products Beta Related Terms


Tarsons Products Beta Historical Data

* Premium members only.

The historical data trend for Tarsons Products's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tarsons Products Beta Chart

Tarsons Products Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 1.27 1.71

Tarsons Products Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.27 1.62 1.83 2.03 1.71

NSE:TARSONS vs ISRG, BDX, MDLN: Beta Comparison

For the Medical Instruments & Supplies subindustry, Tarsons Products's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tarsons Products Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tarsons Products's Beta distribution charts can be found below:

* The bar in red indicates where Tarsons Products's Beta falls into.


NSE:TARSONS
78GF Score
Tarsons Products Ltd NSE:TARSONS
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tarsons Products Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.9480 mean?
Tarsons Products (NSE:TARSONS) has a Beta of 1.9480 as of Jul. 03, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Tarsons Products and its competitors.
Is Tarsons Products' Beta too high?
Tarsons Products' current Beta is 1.9480. Overall, Tarsons Products has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tarsons Products' Beta compare to ISRG and BDX?
Tarsons Products' Beta of 1.9480 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Tarsons Products and its competitors. Tarsons Products's current Beta is 1.9480. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tarsons Products stock overvalued right now?
Based on GuruFocus' analysis, Tarsons Products (NSE:TARSONS) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹564.22, compared to a current price of ₹265.05 — trading 53% below its estimated fair value. The current Beta is 1.9480. Tarsons Products' overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Tarsons Products (NSE:TARSONS), the current Beta is 1.9480 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tarsons Products (NSE:TARSONS) Overvalued in 2026?

Based on GuruFocus' analysis, Tarsons Products stock appears to be undervalued. The current stock price of ₹265.05 is trading 53% below its estimated GF Value™ of ₹564.22. GuruFocus considers Tarsons Products to be Significantly Undervalued.

Key valuation signals for NSE:TARSONS:

  • Beta: 1.9480
  • GF Value™: ₹564.22 vs. price of ₹265.05 (53% below fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the NSE:TARSONS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tarsons Products Business Description

Other Exchanges 543399:India
Address Martin Burn Buisness Park, Room No. 902, BP- 3, Salt Lake, Sector-V, Kolkata, WB, IND, 700091
Tarsons Products Ltd is an Indian labware Company engaged in designing, developing, manufacturing, and marketing consumables, reusables, and other including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, CROs, diagnostic companies, and hospitals. The Company is also engaged in the manufacturing of a wide range of quality labware products that help scientific discovery and improve healthcare. The company generates the majority of its revenue from the sale of manufactured plastic products. Geographically, the company generates the majority of its revenue from India.
78GF Score

Get the complete analysis for NSE:TARSONS

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹265.05
Price
₹564.22
GF Value